|12 Months Ended|
Dec. 31, 2021
12. Stockholders’ Equity
Preferred Stock – The Company has no preferred stock issued. The Company’s amended and restated certificate of incorporation and amended and restated bylaws include provisions that allow the Company’s Board of Directors to issue, without further action by the stockholders, up to shares of undesignated preferred stock.
Common Stock – The Company has one class of common stock outstanding with a total number of shares authorized of . As of December 31, 2021, the Company had shares of common stock outstanding.
In January 2021, the Company issued shares of the Company’s common stock to White Winston as a result of a settlement agreement (see note 10. Commitments and Contingencies).
On February 1, 2021, the Company entered into a private placement with Ms. Yiran Gu, in which the Company sold 1,000,000. shares of its common stock at a price per share of $ for gross proceeds of $
On July 9, 2021, the Company closed the registered direct offering, pursuant to which certain institutional accredited investors purchased 2,499,999.60. shares of the Company’s common stock, par value $ per share, at a per share price equal to $ for gross proceeds of $
On September 22, 2021, the Company entered into a stock purchase agreement with CFL, in which the Company sold 1,000,000. shares of its common stock at a price per share of $ for gross proceeds of approximately $
Total shares issued during fiscal 2021 were as follows:
Schedule of Shares Issued
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef